financetom
Business
financetom
/
Business
/
ED seeks documents from Future Group on disputed Amazon deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ED seeks documents from Future Group on disputed Amazon deal
Nov 8, 2021 3:03 PM

Enforcement Directorate has ordered Future Group to submit documents related to its 2019 deal with Amazon as part of an investigation into possible breach of foreign investment laws, according to sources and a notice seen by Reuters.

The demand indicates heightened scrutiny of a deal which is at the heart of legal battles between Amazon and Future after the Indian company decided to sell its retail assets to rival Reliance Industries for $3.4 billion in 2020.

That transaction has been put on hold by an arbitrator and Indian courts after Amazon argued Future had violated its contracts with the US company by entering into the sale. Future denies that, and says Amazon is illegally exerting control over the Indian firm's business decisions.

In a confidential notice dated October 28, the Enforcement Directorate agency asked a Future unit to submit all correspondence including emails between Amazon and the Indian group in respect of the investment the US firm made in Future two years ago. Reuters has reviewed a copy of the notice.

Two sources with direct knowledge of the matter said the notice was part of an ongoing investigation by the Indian agency to establish whether there were any violations of foreign investment law when Amazon made the $200 million investment in Future's gift voucher unit, Future Coupons.

The notice has not previously been reported and was sent to Future Coupons, which was given 15 days to respond.

The Enforcement Directorate, which typically does not make details of its investigations public, did not respond to a request for comment. Amazon and Future also did not respond.

Disclosure: Network18, the parent company of CNBCTV18.com, is controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.

First Published:Nov 9, 2021 12:03 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved